Most Recent Articles by Brandon May
Researchers evaluated patients with MS to determine whether their unique problems with their sense of smell could be due to inflammatory activity or neurodegeneration.
Investigators observed a clinically relevant slowing of neuronal activity in patients with MS in the parietotemporal cortical areas and the thalamus significantly associated with cognitive impairment.
Hydrocephalus may be a complication of congenital Zika syndrome, with presenting signs and symptoms that are challenging to recognize.
Several randomized controlled trials are underway to confirm the safety and efficacy of early vs late initiation of direct oral anticoagulants in ischemic stroke associated with atrial fibrillation.
Nearly all older adults with Down syndrome now have dementia when they die, making this a vital population to study disease progression, modifying factors, and potential treatments.
More Articles by Brandon May
Aggressive, Prolonged Treatment for Refractory Status Epilepticus May Be Justified With Good Neurologic PrognosisJan 08,2019
Neurology Advisor Articles
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Seizure Monitoring Smartwatch Cleared for Use in Children
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Steps to Facilitate Rapid Reperfusion to Improve Poststroke Outcomes
- Cerebellar Stimulation May Help Improve Gait and Balance Recovery in Stroke
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Risk for Conversion of MS Varies With Different Therapies
- Breakdown of Blood-Brain Barrier May Drive Dementia
- FDA: Food Inspections to Resume Despite Ongoing Funding Lapse
- First Generic Version of Sabril Tablets Gets FDA Approval
- Supine Positioning After Greater Occipital Nerve Block May Improve Outcomes